Zoetis (ZTS) Gross Profit Growth (5y) (2017 - 2026)
Zoetis (ZTS) Gross Profit Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.67 Bn | 34.93 Bn | 1.97 Bn |
| 2 | Zoetis | 30.59 Bn | 28.65 Bn | 1.62 Bn |
| 3 | RedHill Biopharma | 26.22 Bn | 26.22 Bn | - |
| 4 | United Therapeutics | 23.80 Bn | 21.65 Bn | 648.10 Mn |
| 5 | Curaleaf Holdings | 23.70 Bn | 23.70 Bn | 157.29 Mn |
| 6 | Viatris | 18.69 Bn | 16.89 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 16.86 Bn | 15.54 Bn | 800.70 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.57 Bn | 785.00 Mn |
| 9 | Dr Reddys Laboratories | 11.65 Bn | 11.51 Bn | - |
| 10 | Vireo Growth | 10.64 Bn | 10.52 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,376.27% |
| Dec 31, 2025 | 6.79% |
| Sep 30, 2025 | 26.89% |
| Jun 30, 2025 | 22.04% |
| Mar 31, 2025 | 7,151.47% |
| Dec 31, 2024 | 7.07% |
| Sep 30, 2024 | 19.89% |
| Jun 30, 2024 | 26.43% |
| Mar 31, 2024 | 22.06% |
| Dec 31, 2023 | 7.80% |
| Sep 30, 2023 | 7,065.41% |
| Jun 30, 2023 | 23.98% |
| Mar 31, 2023 | 7,006.56% |
| Dec 31, 2022 | 6.70% |
| Sep 30, 2022 | 25.90% |
| Jun 30, 2022 | 28.02% |
| Mar 31, 2022 | 7,264.76% |
| Dec 31, 2021 | 11.06% |
| Sep 30, 2021 | 11.06% |
| Jun 30, 2021 | 11.27% |